Long-term alteration of daily melatonin, 6-Sulfatoxymelatonin, cortisol, and temperature profiles in burn patients: A preliminary report

Chronobiology International

Volumn 27, Issue 2, 2010, Pages 378-392

  Pina, Géraldine ^a   Brun, Jocelyne ^a   Tissot, Sylvie ^a   Claustrat, Bruno ^a,b  

^a HOSPICES CIVILS DE LYON   (France)

^b STEM CELL AND BRAIN RESEARCH INSTITUTE   (France)

Author keywords

6 Sulfatoxymelatonin; Burn patients; Free cortisol; Melatonin; Temperature

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; 6-SULFATOXYMELATONIN; DRUG DERIVATIVE; HYDROCORTISONE; MELATONIN;

ANIMAL; ARTICLE; BODY TEMPERATURE; BURN; CIRCADIAN RHYTHM; FEMALE; HUMAN; INTENSIVE CARE UNIT; MALE; METABOLISM; PHYSIOLOGY; PROSPECTIVE STUDY; URINE;

ANIMALS; BODY TEMPERATURE; BURNS; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYDROCORTISONE; INTENSIVE CARE UNITS; MALE; MELATONIN; PROSPECTIVE STUDIES;

EID: 77950618881     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.3109/07420520903502234     Document Type: Article

References (55)

1. Arendt J, Bojkowski C, Franey C, Wright J, Marks V. (1985). Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: Abolition of the urinary 24-hour rhythm with atenolol. J. Clin. Endocrinol. Metab. 60:1166-1173.
2. Berlin I, Touitou Y, Guillemant S, Danjou P, Puech AJ. (1995). Beta-adrenoceptor agonists do not stimulate daytime melatonin secretion in healthy subjects. Life Sci. 56:325-331.
3. Boeve SA, Aaron LA, Martin-Herz SP, Peterson A, Cain V, Heimbach DM, Patterson DR. (2002). Sleep disturbance after burn injury. J. Burn Care Rehabil. 23:32-38.
4. Bojkowski CJ, Aldhous ME, English J, Franey C, Poulton AL, Skene DJ, Arendt J. (1987). Suppression of nocturnal plasma melatonin and 6-sulfatoxymelatonin by bright and dim light in man. Horm. Metabol. Res. 19:437-440.
5. Brun J, Claustrat B, David M. (1987). Urinary melatonin, LH, oestradiol, progesterone excretion during the menstrual cycle or in women taking oral contraceptives. Acta Endocrinol. 116:145-149.
6. Brun J, Chamba G, Khalfallah Y, Girard P, Boissy I, Bastuji H, Sassolas G, Claustrat B. (1998). Effect of modafinil on plasma melatonin, cortisol and growth hormone rhythms, rectal temperature and performance in healthy subjects during a 36 h sleep deprivation. J. Sleep Res. 7:105-114.
7. Caldwell FT Jr, Graves DB, Wallace BH. (1999). Vagotomy modifies but does not eliminate the increase in body temperature following burn injury in rats. Burns 25:295-305.
8. Chetsawang B, Govitrapong P. (2005). Stimulatory effect of morphine on rat pineal melatonin synthesis via a cyclic AMP-dependent transcription pathway. Neurosci. Lett. 389:57-60.
9. Chuchuen U, Ebadi M, Govitrapong P. (2004). The stimulatory effect of mu- and delta-opioid receptors on bovine pinealocyte melatonin synthesis. J. Pineal Res. 37:223-229.
10. Claustrat B, Chazot G, Brun J, Jordan D, Sassolas G. (1984). A chronobiological study of melatonin and cortisol secretion in depressed subjects: Plasma melatonin, a biochemical marker in major depression. Biol. Psychiatry 19:1215-1228.
11. Claustrat B, Brun J, Chazot G. (2005). The basic physiology and pathophysiology of melatonin. Sleep Med. Rev. 9:11-24.
12. David M, Harthé C, Brun J, Mouren P, Veillas G, Claustrat B. (1987). Plasma catecholamines and melatonin levels during acute exercise in cardiac patients. Neuroendocrinol. Lett. 9:267-272.
13. Davies AO, Lefkowitz RJ. (1980). Corticosteroid-induced differential regulation of beta-adrenergic receptors in circulating human polymorphonuclear leukocytes and mononuclear leukocytes. J. Clin. Endocrinol. Metab. 51:599-605.
14. Faure A, Nemoz C, Claustrat B. (1990). A graphical and statistical method for investigation of time series in chronobiology according to the cosinor procedure. Comput. Biol. Med. 20:319-329.
15. Fischer TW, Slominski A, Zmijewski MA, Reiter RJ, Paus R. (2008). Melatonin as a major skin protectant: From free radical scavenging to DNA damage repair. Exp. Dermatol. 17:713-730.
16. Garrel DR. (1996). Corticosteroid-binding globulin during inflammation and burn injury: Nutritional modulation and clinical implications. Horm. Res. 45:245-251.
17. Gitto E, Karbownik M, Reiter RJ, Tan DX, Cuzzocrea S, Chiurazzi P, Cordaro S, Corona G, Trimarchi G, Barberi I. (2001). Effects of melatonin treatment in septic newborns. Pediatr. Res. 50:756-760.
18. Gronfier C, Simon C, Piquard F, Ehrhart J, Brandenberger G. (1999). Neuroendocrine processes underlying ultradian sleep regulation in man. J. Clin. Endocrinol. Metab. 84:2686-2690.
19. Guerrero JM, Reiter RJ. (2002). Melatonin-immune system relationships. Curr. Top. Med. Chem. 2:167-179.
20. Gunduz-Bruce H. (2009). The acute effects of NMDA antagonism: From the rodent to the human brain. Brain Res. Rev. 60:279-286.
21. Harthé C, Claustrat B, Brun J, Chazot G. (1991). Direct 6-sulfatoxymelatonin radioimmunoassay in plasma with use of an iodinated tracer. Clin. Chem. 37:536-539.
22. Horne J, Östberg O. (1976). A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int. J. Chronobiol. 4:97-110.
23. Horton JW. (2003). Free radicals and lipid peroxidation mediated injury in burn trauma: The role of antioxidant therapy. Toxicology 189:75-88.
24. Jaffe SE, Patterson DR. (2004). Treating sleep problems in patients with burn injuries: Practical considerations. J. Burn Care Rehabil. 25:294-305.
25. Jobin N, Garrel D, Bernier J. (2000). Increased serum-soluble interleukin-2 receptor in burn patients: Characterization and effects on the immune system. Hum. Immunol. 61:233-246.
26. Kennedy SH, Brown GM. (1992). Effect of chronic antidepressant treatment with adinazolam and desipramine on melatonin output. Psychiatry Res. 43:177-185.
27. Kocher L, Brun J, Borson-Chazot F, Gonnaud PM, Claustrat B. (2006). Increased REM sleep associated with melatonin deficiency after pinealectomy: A case study. Chronobiol. Int. 23:889-901
28. Krauchi K. (2007). The human sleep-wake cycle reconsidered from a thermoregulatory point of view. Physiol. Behav. 90:236-245.
29. Krauchi K, Cajochen C, Werth E, Wirz-Justice A. (2000). Functional link between distal vasodilation and sleep-onset latency? Am. J. Physiol. Regul. Integr. Comp. Physiol. 278:741-748.
30. Lack LC, Wright HR. (2007). Treating chronobiological components of chronic insomnia. Sleep Med. 8:637-644.
31. Lewczuk B, Przybylska-Gornowicz B, Wyrzykowski Z. (1999). The effect of morphine on melatonin secretion in the domestic pig. In vivo and in vitro study. Neuro Endocrinol. Lett. 20:171-178.
32. Liu RY, Unmehopa UA, Zhou JN, Swaab DF. (2006). Glucocorticoids suppress vasopressin gene expression in human suprachiasmatic nucleus. J. Steroid. Biochem. Mol. Biol. 98:248-253.
33. Maldonado MD, Murillo-Cabezas F, Calvo JR, Lardone PJ, Tan DX, Guerrero JM, Reiter R. (2007). Melatonin as pharmacologic support in burn patients: A proposed solution to thermal injuryrelated lymphocytopenia and oxidative damage. Crit. Care Med. 35:1-9.
34. Molteni A, Warpeha RL, Brizio-Molteni L, Albertson DF, Kaurs R. (1979). Circadian rhythms of serum aldosterone, cortisol and plasma renin activity in burn injuries. Ann. Clin. Lab. Sci. 9:518-523.
35. Mundigler G, Delle-Karth G, Koreny M, Zehetgruber M, Steindl-Munda P, Marktl W, Fertl L, Siostrzonek P. (2002). Impaired circadian rhythm of melatonin secretion in sedated critically ill patients with severe sepsis. Crit. Care Med. 30:536-540.
36. Murphy BE. (1968). Clinical evaluation of urinary cortisol determinations by competitive proteinbinding radioassay. J. Clin. Endocrinol. Metab. 28:343-348.
37. Paakkonen T, Makinen TM, Leppaluoto J, Vakkuri O, Rintamaki H, Palinkas LA, Hassi J. (2006). Urinary melatonin: A non-invasive method to follow human pineal function as studied in three experimental conditions. J. Pineal Res. 40:110-115.
38. Pandit SK, Malla CN, Zarger HU, Kaul A, Dev G. (1993). A study of bone and joint changes secondary to burns. Burns 19:227-228.
39. Peteiro-Cartelle FJ, Alvarez-Jorge A. (1999). Dynamic profiles of interleukin-6 and the soluble form of CD25 in burned patients. Burns 25:487-491.
40. Portaluppi F, Touitou Y, Smolensky MH. (2008). Ethical and methodological standards for laboratory and medical biological rhythm research. Chronobiol. Int. 25:999-1016.
41. Raymond I, Ancoli-Israel S, Choiniere M. (2004). Sleep disturbances, pain and analgesia in adults hospitalized for burn injuries. Sleep Med. 5:551-559.
42. Reiter RJ, Tan DX, Osuna C, Gitto E. (2000). Actions of melatonin in the reduction of oxidative stress. A review. J. Biomed. Sci. 7:444-458.
43. Reiter RJ, Tan DX, Maldonado MD. (2005). Melatonin as an antioxidant: Physiology versus pharmacology. J. Pineal Res. 39:215-216.
44. Slominski A, Wortsman J, Tobin DJ. (2005). The cutaneous serotoninergic/melatoninergic system: Securing a place under the sun. FASEB J. 19:176-194.
45. Strassmann RJ, Qualls CR, Lisansky EJ, Peake GT. (1991). Elevated rectal temperature produced by all-night bright light is reversed by melatonin infusion in men. J. Appl. Physiol. 71:2178-2182.
46. Tan DX, Reiter RJ, Manchester LC, Mayo JC, Sainz RM, Lopez-Burillo S. (2002). Chemical and physical properties and potential mechanisms: Melatonin as a broad spectrum antioxidant and free radical scavenger. Curr. Topics Med. Chem. 2:181-198.
47. Tobiasen J, Hiebert JM, Edlich RF. (1982). The abbreviated burn severity index. Ann. Emerg. Med. 11:260-262.
48. Tunali T, Sener G, Yarat A, Emekli N. (2005). Melatonin reduces oxidative damage to skin and normalizes blood coagulation in a rat model of thermal injury. Life Sci. 76:1259-1265.
49. Vaughan GM, Becker RA, Allen JP, Goodwin CW Jr., Pruitt BA Jr, Mason AD Jr. (1982). Cortisol and corticotrophin in burned patients. J. Trauma 22:263-273.
50. Vaughan GM, Taylor TJ, Pruitt BA Jr., Mason AD Jr. (1985). Pineal function in burns: Melatonin is not a marker for general sympathetic activity. J. Pineal Res. 2:1-12.
51. Vgontzas AN, Chrousos GP. (2002). Sleep, the hypothalamic-pituitary- adrenal axis, and cytokines: Multiple interactions and disturbances in sleep disorders. Endocrinol. Metab. Clin. North Am. 31:15-36.
52. Vuillez P, Jacob N, Teclemariam-Mesbah R, Van Rossum A, Vivien-Roels B, Pévet P. (1998). Effect of NMDA receptor antagonist MK-801 on light-induced Fos expression in the suprachiasmatic nuclei and on melatonin production in the Syrian hamster. J. Neuroendocrinol. 10:671-677.
53. Ward PA, Till GO. (1990). Pathophysiologic events related to thermal injury of skin. J. Trauma 30:S75-S79.
54. Withyachumnarnkul B, Nonaka KO, Santana C, Attia AM, Reiter RJ. (1990). Interferon-gamma modulates melatonin production in rat pineal glands in organ culture. J. Interferon Res. 10:403-411.
55. Zuther P, Lemmer B. (2005). Chronos-Fit. Available at: http://www.ma.uni-heidelberg.de/inst/phar/ forschungLemmer.html